Literature DB >> 8810349

Mutagenesis analysis of functionally important domains within the C-terminal end of smooth muscle caldesmon.

Z Wang1, S Chacko.   

Abstract

The ability of chicken gizzard smooth muscle caldesmon (CaD) to inhibit actomyosin ATPase activity is due mainly to an inhibitory domain that resides within the C-terminal 67 amino acid residues of the CaD molecule. In the present study, a series of C-terminal truncation and internal deletion mutants of chicken gizzard smooth muscle CaD were systematically designed using a site-directed mutagenesis approach, and these mutant proteins were overexpressed in a baculovirus expression system. Analysis of actin binding and inhibition of actomyosin ATPase activity using these mutants identified a strong actin-binding motif of 6 amino acid residues (from Lys718 to Glu723), which also form the core sequence for CaD-induced inhibition of actomyosin ATPase. However, maximal inhibition by CaD requires the presence of residues 728-731, which are not associated with actin binding. Our data provide direct evidence for the requirement of actin binding to a specific region in CaD for CaD-induced inhibition of actin activation of smooth muscle myosin ATPase. Furthermore, our findings also show that the region between residues 690 and 717 is responsible for the weak inhibition of actomyosin ATPase and reveal that the inhibitory determinants located in the regions between residues 690 and 717 and residues 718 and 756 can function independently.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8810349     DOI: 10.1074/jbc.271.41.25707

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  5 in total

1.  Both N-terminal myosin-binding and C-terminal actin-binding sites on smooth muscle caldesmon are required for caldesmon-mediated inhibition of actin filament velocity.

Authors:  Z Wang; H Jiang; Z Q Yang; S Chacko
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

2.  Characterization of the functional properties of smooth muscle caldesmon domain 4a: evidence for an independent inhibitory actin-tropomyosin binding domain.

Authors:  M El-Mezgueldi; O Copeland; I D Fraser; S B Marston; P A Huber
Journal:  Biochem J       Date:  1998-06-01       Impact factor: 3.857

3.  Caldesmon inhibits nonmuscle cell contractility and interferes with the formation of focal adhesions.

Authors:  D M Helfman; E T Levy; C Berthier; M Shtutman; D Riveline; I Grosheva; A Lachish-Zalait; M Elbaum; A D Bershadsky
Journal:  Mol Biol Cell       Date:  1999-10       Impact factor: 4.138

4.  Amino acid mutations in the caldesmon COOH-terminal functional domain increase force generation in bladder smooth muscle.

Authors:  Maoxian Deng; Ettickan Boopathi; Joseph A Hypolite; Tobias Raabe; Shaohua Chang; Stephen Zderic; Alan J Wein; Samuel Chacko
Journal:  Am J Physiol Renal Physiol       Date:  2013-08-28

5.  Smooth muscle hypertrophy following partial bladder outlet obstruction is associated with overexpression of non-muscle caldesmon.

Authors:  Erik Y Zhang; Raimund Stein; Shaohua Chang; Yongmu Zheng; Stephen A Zderic; Alan J Wein; Samuel Chacko
Journal:  Am J Pathol       Date:  2004-02       Impact factor: 4.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.